Center-Authored Papers

Filters: Author is Coveler, Andrew L  [Clear All Filters]
Journal Article
Coveler AL, Rossi GR, Vahanian NN, Link C, Chiorean GE.  2016.  Algenpantucel-L immunotherapy in pancreatic adenocarcinoma.. Immunotherapy. Abstract
Birzele F, Voss E, Nopora A, Honold K, Heil F, Lohmann S, Verheul H, Le Tourneau C, Delord J-P, van Herpen C et al..  2015.  CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Coveler AL, Goodell V, Webster DJ, Salazar LG, Fintak PA, Childs JS, Higgins DM, Disis ML.  2009.  Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity.. Breast cancer research and treatment. 113(1):95-100. Abstract
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
der Houven van Oordt WM-vanC, Gomez-Roca C, van Herpen C, Coveler AL, Mahalingam D, Verheul HMW, van der Graaf WTA, Christen R, Rüttinger D, Weigand S et al..  2016.  First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors.. Oncotarget. Abstract
Disis ML, Dang Y, Coveler AL, Marzbani E, Kou ZC, Childs JS, Fintak P, Higgins DM, Reichow J, Waisman J et al..  2014.  HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers.. Cancer immunology, immunotherapy : CII. 63(2):101-9. Abstract
Coveler AL, Herman JM, Simeone DM, Chiorean GE.  2016.  Localized Pancreatic Cancer: Multidisciplinary Management.. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. 35:e217-26. Abstract
McCormick KA, Coveler AL, Rossi GR, Vahanian NN, Link C, Chiorean GE.  2016.  Pancreatic cancer: Update on Immunotherapies and Algenpantucel-L.. Human vaccines & immunotherapeutics. 12(3):563-575. Abstract
Coveler AL, Ko AH, Catenacci DVT, Von Hoff D, Becerra C, Whiting NC, Yang J, Wolpin B.  2016.  A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers.. Investigational new drugs. Abstract
Wong KM, Horton KJ, Coveler AL, Hingorani SR, Harris WP.  2017.  Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).. Current oncology reports. 19(7):47. Abstract
Salazar LG, Lu H, Reichow JL, Childs JS, Coveler AL, Higgins DM, Waisman J, Allison KH, Dang Y, Disis ML.  2017.  Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial.. JAMA oncology. Abstract